IMGN : Analysis & Opinions
October 2, 2012Roche Holdings Ltd. (RHHBY) recently announced additional results from its phase III EMILIA study, which was conducted with ...
August 27, 2012The market is on the rise this morning. The Nasdaq is up 0.5%; the S&P 500 has risen 0.3%; and the Dow has climbed 0.1%. ...
August 27, 2010Roche suffers another setback to its key cancer franchise, while ImmunoGen faces a major delay in royalty payments.